Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HoyaTSE:7741 -1.92%99 3-1 Month Momentum % is 2.34% as of Sep. 11, 2026. GuruFocus rates TSE:7741 with a GF Score™ of 99/100 and a GF Value™ of 円25,639.10 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 848 Medical Devices & Instruments companies, Hoya ranks better than 53.89% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-11), Hoya's 3-1 Month Momentum % is 2.34%.
The industry rank for Hoya's 3-1 Month Momentum % or its related term are showing as below:
TSE:7741's 3-1 Month Momentum % is ranked better than 53.89% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 0.86
vs TSE:7741: 2.34
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Hoya 3-1 Month Momentum % Related Terms
TSE:7741 vs ISRG, BDX, RMD: 3-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, Hoya's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoya 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hoya's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Hoya's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hoya (TSE:7741) has a 3-1 Month Momentum % of 2.34% as of Sep. 11, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Hoya and its competitors. According to the industry distribution chart, Hoya ranks #391 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 46.1%.
Is Hoya's 3-1 Month Momentum % too high?
Hoya's current 3-1 Month Momentum % is 2.34%. The Medical Devices & Instruments industry median 3-1 Month Momentum % is 0.86. Hoya's value of 2.34% is 172.1% above this industry median. Based on the distribution chart, Hoya ranks #391 out of 848 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hoya has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hoya's 3-1 Month Momentum % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hoya ranks #391 out of 848 companies for 3-1 Month Momentum %. This puts Hoya in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.86. Hoya's value of 2.34% is 172.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.86, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoya's current 3-1 Month Momentum % of 2.34% is 172.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Hoya and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoya's current 3-1 Month Momentum % is 2.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoya stock overvalued right now?
Based on GuruFocus' analysis, Hoya (TSE:7741) is currently considered Modestly Undervalued. The stock's GF Value™ is 円25,639.10, compared to a current price of 円22,690.00 — trading 11.5% below its estimated fair value. The current 3-1 Month Momentum % is 2.34% and 172.1% above the Medical Devices & Instruments industry median of 0.86. Hoya's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Hoya (TSE:7741), the current 3-1 Month Momentum % is 2.34% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoya (TSE:7741) Overvalued in 2026?
Based on GuruFocus' analysis, Hoya stock appears to be undervalued.
The current stock price of 円22,690.00 is trading 11.5% below its estimated GF Value™ of 円25,639.10.
GuruFocus considers Hoya to be Modestly Undervalued.
Key valuation signals for TSE:7741:
3-1 Month Momentum %: 2.34%
GF Value™: 円25,639.10 vs. price of 円22,690.00 (11.5% below fair value)
Industry Position: 172.1% above the Medical Devices & Instruments median (#391 of 848)
No single metric tells the full story. See the TSE:7741 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 1941 in Tokyo as an optical glass production plant, Hoya is one of the largest eyeglass lens manufacturers in the world. Leveraging its technology know-how in glass manufacturing, Hoya entered the mask blanks business in 1974. Now although its life care business accounts for more than 60% of its total revenue, majority of its profit before tax comes from its higher-margin IT business.
99GF Score
Get the complete analysis for TSE:7741
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7741 has been successfully added to your 
